FINCH THERAPEUTICS GROUP INC's ticker is FNCH and the CUSIP is 31773D101. A total of 44 filers reported holding FINCH THERAPEUTICS GROUP INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $291 | -18.0% | 739,136 | 0.0% | 0.02% | -21.7% |
| Q4 2022 | $355 | -100.0% | 739,136 | 0.0% | 0.02% | -74.4% |
| Q3 2022 | $1,234,000 | -41.2% | 739,136 | 0.0% | 0.09% | -40.0% |
| Q2 2022 | $2,099,000 | -43.5% | 739,136 | 0.0% | 0.15% | -36.7% |
| Q1 2022 | $3,718,000 | -49.5% | 739,136 | 0.0% | 0.24% | -49.0% |
| Q4 2021 | $7,369,000 | -10.9% | 739,136 | +16.2% | 0.46% | -47.5% |
| Q3 2021 | $8,271,000 | – | 636,195 | – | 0.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avenir Management Company, LLC | 55,445 | $472,946 | 1.27% |